Health
Olfactory and gustatory impairments in COVID‐19 patients: Role in early diagnosis and interferences by concomitant drugs – Ferraro – – British Journal of Clinical Pharmacology – Wiley Online Library – Wiley
Click on the article title to read more.
The COVID19 pandemic spread worldwide with over 38 million confirmed cases and more than 1 million deaths as of October 15, 2020. The clinical manifestations of SARSCoV2 infection range from asymptomatic to lifethreatening pneumonia, with the main symptoms being respiratory and gastrointestinal in nature. However, several patients report neurological symptoms including smell and taste impairments, such as anosmia, cacosmia, ageusia and dysgeusia.1 Although the spread of the disease has been favoured…
-
Noosa News13 hours agoCommissioner thanks police officer who threw a speed radar at a car
-
Noosa News21 hours agoDifficult to diagnose and potentially deadly — this lesser-known disease is becoming more common
-
Noosa News12 hours agoDefence investigation finds Taipan pilot’s actions possibly prevented further fatalities in crash
-
Noosa News22 hours agoCountdown on for Noosa Eat & Drink Festival 2025